Cover Image
市場調查報告書

整形外科用生醫材料的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及的2015∼2021年的預測

Global Orthopedic Biomaterials Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 346115
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
整形外科用生醫材料的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及的2015∼2021年的預測 Global Orthopedic Biomaterials Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年03月31日 內容資訊: 英文 140 Pages
簡介

整形外科用生醫材料市場預計2015∼2021年以年複合成長率11%擴大。整形外科用生醫材料用於骨植入的製造,有助於修復損傷的骨和關節結構。整形外科手術的增加與昂貴的醫療費、新興市場上可支配所得的增加等,成為促進市場的要素。

本報告提供全球整形外科用生醫材料市場相關調查、市場趨勢以及到2021年的收益預測與成長率、產業分析、競爭趨勢、各地區趨勢,及進入的主要企業簡介彙整。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 市場趨勢
  • 競爭情報
  • 價值鏈分析
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
    • 研究開發的政府和民營企業的融資擴大
    • 聚合物為基礎的生醫材料的增產
    • 高齡化和文明病的罹患率
    • 技術進步
  • 阻礙市場的要素
    • 生醫材料的適合性
    • 政府的政策
    • 術後的問題
  • 市場課題
    • 生醫材料的價格高
    • 新興市場上研究開發的不足
  • 市場機會
    • 組織工程的發展
    • 新興市場

第4章 部門分析

第5章 市場區隔

  • 各類型
  • 各用途
  • 各產品

第6章 競爭情報

  • 市場佔有率
  • 策略

第7章 各地區分析

  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 亞太地區
  • 其他

第8章 企業簡介

  • Genzyme Corporation
  • Carpenter Technology Corporation
  • Materion Corporation
  • Ulbrich Stainless Steel & Special Metals, Inc.
  • Heraeus Medical Components
  • CeramTec (a subsidiary of Rockwood Holdings Inc.)
  • Ceradyne, Inc.
  • Kyocera Corporation
  • Bayer
  • Purac Biomaterials
  • DSM Biomedical Inc.
  • Evonik Industries AG
  • Cam Bioceramics B.V.
  • Ticona GmbH
  • Osteotech, Inc.
  • Starch Medical, Inc.
  • Landec Corporation.
  • Biomet
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Wright Medical Group
  • Zimmer Holdings
  • Etex Corp
  • Invibo PEEK biomaterial solutions
  • Biocoat Incorporated
  • Biocomposites Ltd
  • Collagen Matrix Inc.
  • Integra lifesciences Inc.
  • NovaBone Products LLC

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HAD-1251015

Orthopedic materials are defined as materials used for internal fracture fixation; biomaterials are used for manufacturing bone implants. Biomaterials are composed of organic or synthetic materials. Biomaterials help in repairing the structural integrity of the damaged bones and joints. The biomaterials are implanted to perform the role of pre-existing damaged tissues such as bones, ligaments and tendons. Some of the key factors that have a major impact on the orthopedic biomaterials market are growing acceptance of biomaterials with more research and development assisting the market growth. Orthopaedic surgeries are on a rise, high healthcare expenditure and disposable income of emerging market are also driving the market. High number of bone and joint related degenerative problems is one of the major drivers. The implants are used in the case of diseases such as osteoporosis, arthritis, tumors, trauma, tissue injuries and other bone related issues.

The market is segmented on the basis of products, application and biomaterials type. The biomaterials type includes metals and non-metals. Metals include stainless steel, titanium and cobalt alloys; non metals include ceramics, polymers and composites. Application of biomaterials includes orthobiologics, joint replacements, Viscosupplementation and others. Products include bone allografts, aligned bone matrix, machined bones, bone morphogenetic protein, synthetic bone substitute and others.

The market is driven by high expenditure in the research and development field. New biomaterials are being developed which are more compatible to human body. One of the major issues faced by manufacturers, physicians and patients alike is the biocompatibility of the products. Manufacturers are working on various new biomaterials and developing tissue reengineering techniques. Polymer based biodegradable biomaterials are being produced at a higher volume such as polyglycolic acid and polylactic acids. These polymers can easily be placed, as the implants are removed the callus strength increases. The hardware removal is not necessary therefore reducing the cost. High prevalence of age related lifestyle diseases and increasing number of elderly population is also driving the market.

North America has the highest market share whereas Asia Pacific is expected to grow in the future. The market is highly competitive and consists of some major player such as Genzyme Corporation, Carpenter Technology Corporation, and Materion Corporation. Ulbrich Stainless Steel & Special Metals, Inc., Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), Ceradyne, Inc., Kyocera Corporation, Bayer, Purac Biomaterials and others.

Companies Profiled

  • 1. Genzyme Corporation
  • 2. Carpenter Technology Corporation
  • 3. Materion Corporation
  • 4. Ulbrich Stainless Steel & Special Metals, Inc
  • 5. Heraeus Medical Components
  • 6. CeramTec (a subsidiary of Rockwood Holdings Inc)
  • 7. Ceradyne, Inc
  • 8. Kyocera Corporation
  • 9. Bayer
  • 10. Purac Biomaterials
  • 11. DSM Biomedical Inc
  • 12. Evonik Industries AG
  • 13. Cam Bioceramics BV
  • 14. Ticona GmbH
  • 15. Osteotech, Inc
  • 16. Starch Medical, Inc Landec Corporation
  • 17. Biomet
  • 18. DePuy Synthes
  • 19. Medtronic
  • 20. Stryker
  • 21. Wright Medical Group
  • 22. Zimmer Holdings
  • 23. Etex Corp
  • 24. Invibo PEEK biomaterial solutions
  • 25. Biocoat Incorporated
  • 26. Biocomposites Ltd
  • 27. Collagen Matrix Inc
  • 28. Integra lifesciences Inc
  • 29. NovaBone Products LLC

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. In-depth profiling of companies

Table of Contents

1. Introduction

  • 1.1. Executive summary
  • 1.2. Estimation methodology

2. Market overview

  • 2.1. Market definition and scope
  • 2.2. Key findings
  • 2.3. Parametric analysis
    • 2.3.1. Global orthopedic implants market
    • 2.3.2. Global orthopedic surgeries
    • 2.3.3. Unit shipments for implants
    • 2.3.4. Healthcare expenditure across geographies
    • 2.3.5. Disposable income of top emerging economies
  • 2.4. Key market insights
    • 2.4.1. Top 3 emerging countries
    • 2.4.2. Top 3 revenue generating segments
    • 2.4.3. Top growing markets and emerging trends
    • 2.4.4. R&D scenario in biomaterial market
    • 2.4.5. Pricing analysis
  • 2.5. Competitive intelligence
    • 2.5.1. Market share analysis
    • 2.5.2. Top winning strategies
    • 2.5.3. Case studies: Top competitive moves
  • 2.6. Value Chain analysis
  • 2.7. Key buying criteria
  • 2.8. Strategic recommendation
  • 2.9. Strategic conclusions

3. Market determinants

  • 3.1. Market drivers
    • 3.1.1. Increased funding by government and private firms in research and development
    • 3.1.2. High production of polymer based biomaterials
    • 3.1.3. High elderly population and prevalence of lifestyle diseases
    • 3.1.4. Technology advancements
  • 3.2. Market Restraints
    • 3.2.1. Compatibility of biomaterials with recipient
    • 3.2.2. Government policies
    • 3.2.3. Post surgery issues
  • 3.3. Market challenges
    • 3.3.1. High price of biomaterials
    • 3.3.2. Weak research and development in emerging markets
  • 3.4. Market opportunities
    • 3.4.1. Development of tissue engineering
    • 3.4.2. Markets in emerging geographies

4. Sector Analysis

  • 4.1. Parent market
  • 4.2. Sub-segment market
  • 4.3. Alternative market

5. Market Segmentation

  • 5.1. Global orthopedics biomaterials market, by types, 2014-2021, ($millions)
    • 5.1.1. Global metallic orthopedics biomaterials market, 2014-2021, ($millions)
      • 5.1.1.1. Global stainless orthopedics biomaterials market, 2014-2021, ($millions)
      • 5.1.1.2. Global titanium orthopedics biomaterials market, 2014-2021, ($millions)
      • 5.1.1.3. Global cobalt alloys orthopedics biomaterials market, 2014-2021, ($millions)
    • 5.1.2. Global non-metallic orthopedics biomaterials market, 2014-2021, ($millions)
      • 5.1.2.1. Global polymers orthopedics biomaterials market, 2014-2021, ($millions)
        • 5.1.2.1.1. Global Ultrahigh molecular weight polyethylene (UHMWPE) market, 2014-2021, ($millions)
        • 5.1.2.1.2. Global Acrylic bone cements market, 2014-2021, ($millions)
        • 5.1.2.1.3. Global Thermoplastic polyether ether ketone (PEEK) market, 2014-2021, ($millions)
        • 5.1.2.1.4. Global Bioabsorbables market, 2014-2021, ($millions)
      • 5.1.2.2. Global ceramics orthopedics biomaterials market, 2014-2021, ($millions)
        • 5.1.2.2.1. Global alumina market, 2014-2021, ($millions)
        • 5.1.2.2.2. Global zirconia market, 2014-2021, ($millions)
        • 5.1.2.2.3. Global hydroxyapatite market, 2014-2021, ($millions)
      • 5.1.2.3. Global Composites orthopedics biomaterials market, 2014-2021, ($millions)
        • 5.1.2.3.1. Global Fiber-reinforced polymers market, 2014-2021, ($millions)
        • 5.1.2.3.2. Global Aggregates to polymethyl methacrylate (PMMA) market, 2014-2021, ($millions)
  • 5.2. Global orthopedic biomaterial market, by application, 2014-2021
    • 5.2.1. Global orthobiologics orthopedics biomaterials market, 2014-2021, ($millions)
    • 5.2.2. Global joint replacements orthopedics biomaterials market, 2014-2021, ($millions)
    • 5.2.3. Global viscosupplementation orthopedics biomaterials market, 2014-2021, ($millions)
    • 5.2.4. Global bioresorbable tissue fixation products market, 2014-2021, ($millions)
    • 5.2.5. Global non-conventional modular tumor implants market, 2014-2021, ($millions)
    • 5.2.6. Global spine implants market, 2014-2021, ($millions)
  • 5.3. Global orthopedic materials market, by products, 2014-2021, ($millions)
    • 5.3.1. Global bone allografts market, 2014-2021, ($millions)
    • 5.3.2. Global machined bones2014-2021, ($millions)
    • 5.3.3. Global dematerialized Bone Matrix (DBM) 2014-2021, ($millions)
    • 5.3.4. Global bone morphogenetic Protein (BMP) 2014-2021, ($millions)
    • 5.3.5. Global stem cell therapy2014-2021, ($millions)
    • 5.3.6. Global synthetic bone substitute2014-2021, ($millions)

6. Competitive Landscape

  • 6.1. Market share
  • 6.2. Strategy - An analysis across tiers

7. Geographical analysis

  • 7.1. North America orthopedic biomaterials market, 2014-2021, ($millions)
  • 7.2. United States (U.S.) orthopedic biomaterials market, 2014-2021, ($millions)
  • 7.3. Canada orthopedic biomaterials market, 2014-2021, ($millions)
  • 7.4. Europe orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.1. United Kingdom (UK) orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.2. France orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.3. Germany orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.4. Spain orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.5. Italy orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.4.6. RoE orthopedic biomaterials market, 2014-2021, ($millions)
  • 7.5. Asia Pacific orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.1. India orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.2. China orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.3. Japan orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.4. Korea orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.5. Australia orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.5.6. RoAPAC orthopedic biomaterials market, 2014-2021, ($millions)
  • 7.6. Rest of the world orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.6.1. Latin America orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.6.2. MENA orthopedic biomaterials market, 2014-2021, ($millions)
    • 7.6.3. Africa orthopedic biomaterials market, 2014-2021, ($millions)

8. Company Profiles:

  • 8.1. Genzyme Corporation
  • 8.2. Carpenter Technology Corporation
  • 8.3. Materion Corporation
  • 8.4. Ulbrich Stainless Steel & Special Metals, Inc.
  • 8.5. Heraeus Medical Components
  • 8.6. CeramTec (a subsidiary of Rockwood Holdings Inc.)
  • 8.7. Ceradyne, Inc.
  • 8.8. Kyocera Corporation
  • 8.9. Bayer
  • 8.10. Purac Biomaterials
  • 8.11. DSM Biomedical Inc.
  • 8.12. Evonik Industries AG
  • 8.13. Cam Bioceramics B.V.
  • 8.14. Ticona GmbH
  • 8.15. Osteotech, Inc.
  • 8.16. Starch Medical, Inc.
  • 8.17. Landec Corporation.
  • 8.18. Biomet
  • 8.19. DePuy Synthes
  • 8.20. Medtronic
  • 8.21. Stryker
  • 8.22. Wright Medical Group
  • 8.23. Zimmer Holdings
  • 8.24. Etex Corp
  • 8.25. Invibo PEEK biomaterial solutions
  • 8.26. Biocoat Incorporated
  • 8.27. Biocomposites Ltd
  • 8.28. Collagen Matrix Inc.
  • 8.29. Integra lifesciences Inc.
  • 8.30. NovaBone Products LLC
Back to Top